Facebook Twitter LinkedIn

Annual Report

0%

2018 revenue growth

€0m

2018 Revenue

€0m

2018 adjusted EBITDA

Performance

  • Revenue

    €0m

  • Adjusted EBITDA

    €0m

  • Revenue per share 2018

    €0

  • Revenue per share 2017

    €0

  • Organic Revenue Growth (Q4 18 vs Q4 17)

    0%

Objectives for 2019

  • 1

    Continue to strengthen product portfolio

  • 2

    Drive organic revenue from product sales and licensing

  • 3

    Potentially add complementary acquisition

Financial Outlook for 2019

  • 1

    Revenues: double digit revenue growth

  • 2

    EBITDA: adjusted EBITDA EUR >2 million

Strategic investment

Innovation & Intellectual Property

We are a company driven by innovation, investing around 10% of turnover in research & development of new products. Innovation is what drives product development at Expedeon. Our objective is to move boundaries and develop products which will assist with the advancement of life sciences and healthcare as a whole. Through innovation, we are able to protect our intellectual property by means of patents which in turn provides us with a strong competitive position in the market place allowing our products to attract premium pricing and deliver high gross margins.

Commercial Capability

We sell our offering predominantly through our own sales and marketing infrastructure alongside a global network of distributors to facilitate rapid market penetration. We have made substantial investments in developing and expanding our direct sales and marketing reach and capabilities. The Company now operates a comprehensive e-marketing platform which drives new lead generation and is supported by an extensive key account management system focused on delivering cross-selling opportunities within the existing customer base. The combination of strong new account development in conjunction with extensive cross-selling are the key drivers for sustained strong organic growth.

Download

Use the form below to download a copy of our Annual Report